Zhejiang Hisun Pharmaceutical Co. Ltd.

The turn of the year witnessed a spike in venture capital and private equity funding deals in China, with several valued at around the $100m level. A string of four large financings around late Decemb

Although it may be a common career path to advise the pharmaceutical industry on quality as a consultant or employee after providing free advice for years as a US Food and Drug Administration enforcem

Anticancer drugs continued to take up the lion's share of the novel drugs that gained approval in China in the first half of 2021, information compiled by the Pink Sheet based on official data shows

Hoth Licenses VCU Research On Halting Spike Protein Binding Hoth Therapeutics Inc. announced on 20 May that it is licensing technology and related intellectual property developed at Virginia Common